Legal updates and opinions
News / News
Compensation for employees who experience injuries, illness or death as a result of the Covid-19 vaccine
Compensation for Occupational Injuries and Diseases Act 130 of 1993
by Jacques van Wyk, Director and Andre van Heerden, Senior Associate
On 22 October 2021, a notice was published in the Government Gazette in terms of section 6A(b) of the Compensation for Occupational Injuries and Diseases Act 130 of 1993 (“COIDA“). The notice relates to the compensation for side effects to the Covid-19 vaccination (“Notice“) based on employees who experience injuries, illness or death as a result of the Covid-19 vaccine in the circumstances where the requirement to have the vaccine is an inherent requirement of the employee’s job or where the employee is required to do so in terms of his/her employer’s risk assessment.
Read our article discussing vaccination policies for the workplace for more on the implementation of a mandatory vaccination policy and the required risk assessment).
The Notice provides that if an employee is required to receive a Covid-19 vaccine, either as a result of an occupational health and safety risk assessment conducted by an employer or where the vaccine is an inherent requirement of employment, any injury, illness or death incurred as a result will be covered by the Compensation Fund.
However, in order for such cover to extend to an employee, there are 6 requirements that apply:
- The vaccine must be regarded as an inherent requirement of employment in terms of the employer’s risk assessment;
- The employee must have received a SAHPRA-approved Covid-19 vaccine;
- Evidence of the employer’s risk assessment and vaccination plan in terms of the Consolidated Directions on Occupational Health and Safety Measures in Certain Workplaces must be provided;
- The chronological sequence between the vaccine inoculation and the development of the employee’s symptoms and clinical signs must be provided;
- The employee must have presented with symptoms and clinical signs that are generally recognised as side effects of the Covid-19 vaccine; and
- Additional tests may be required to assess the presence of abnormalities of any organ affected.
A copy of the Notice can be accessed here.
Latest News
AI Quality Management under the EU AI Act: Principles, Obligations and the Links to GDPR and POPIA
by Ahmore Burger-Smidt, Director and Head of Regulatory, and Boitumelo Khwene, Candidate Attorney "The EU AI Act asks a simple [...]
Confidence is not capability (Part 2): Governing AI in the age of the rogue agent
by Ahmore Burger-Smidt, Director and Head of Regulatory In Part 1, “Confidence Is Not Capability (Part 1): What the Data [...]
Confidence is not capability (Part 1): What the data shows, and why POPIA is the foundation of cyber resilience
by Ahmore Burger-Smidt, Director and Head of Regulatory A two-part series drawing on the Data Confidence & AI Readiness in [...]
SABS publishes draft AI standards for public comment
by Wendy Rosenberg, Director and Head of Digital Media & Electronic Communications The South African Bureau of Standards (SABS) has [...]
Too old for the package? Labour Court draws the line on age-based severance
by Bradley Workman-Davies, Director The Labour Court’s decision in Bosch v Passenger Rail Agency of SA provides employers with a [...]
Proposed Amendments to the Mandatory Mediation Protocol in the Gauteng Division of the High Court: Will the latest attempt to redirect judicial traffic succeed?
by Dakalo Singo, Director and Head of Pro Bono, and Wamkelwe Ntuli, Candidate Attorney Introduction The Gauteng Division of the [...]
